REQUEST A DEMO
Total
USD $0.00
Search more companies

Direct Pharma Polska Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Direct Pharma Polska Sp. z o.o. Profile Updated: February 27, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Direct Pharma Polska Sp. z o.o. is a company based in Poland, with its head office in Krakow. It operates in the Pharmaceutical Preparation Manufacturing sector. Direct Pharma Polska Sp. z o.o. was incorporated on March 07, 2018. From the latest financial highlights, Direct Pharma Polska Sp. z o.o. reported a net sales revenue drop of 69.22% in 2023. Its total assets grew by 8.6% over the same period. In, 2023, the company’s net profit margin decreased by 28.33%.

Headquarters
Ul. Zygmunta Radnickiego 11
Krakow; Malopolskie; Postal Code: 30-498

Contact Details: Purchase the Direct Pharma Polska Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Direct Pharma Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Direct Pharma Polska Sp. z o.o. report to view the information.
Incorporation Date:
March 07, 2018
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
59.75%
Purchase this report to view the information.
20.13%
Purchase this report to view the information.
20.13%
Company Performance
Financial values in the chart are available after Direct Pharma Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-69.22%
Total operating revenue
-69.28%
Operating profit (EBIT)
24.16%
Net Profit (Loss) for the Period
35.59%
Total assets
8.6%
Total equity
-1570.31%
Operating Profit Margin (ROS)
-32.15%
Net Profit Margin
-28.33%
Return on Equity (ROE)
-1732.96%
Debt to Equity Ratio
2120.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?